ImQuest is a preclinical and infectious disease CRO that provides expert services to evaluate novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases.

Let us assist with your R&D outsourcing needs, including:

• Comprehensive compound screening to define target efficacy.
• Drug target validation, mechanism of action, drug combination and toxicity evaluations
• Services for small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines.
• Diverse client portfolio: pharmaceutical companies, large and mid-sized biotechnology companies, start-up and virtual companies, and academic investigators.
• Extensive preclinical and infectious disease specialty services: virus, bacteria, in vitro toxicology, and cancer testing and drug screening support.
• Custom assay development and outsourced research and development support.